SEC Form 4
Guardian Pharmacy Services, Inc. (GRDN) insider trading
In the 12 months to Oct 26, 2026, 9 GRDN insiders reported open-market sales of $419.3M across 9 filings; one director bought $99.8K.
Latest filing · Last 12 months · Source: SEC EDGAR · How we count
- Open-market sales
- $419.3M
- 9 filings · 9 insiders
- Open-market purchases
- $99.8K
- 1 filing · Steven D. Cosler, Director
Who traded GRDN, and when
- Purchase
- Sale
GRDN daily close from Oct 27, 2025 to Oct 26, 2026, between $27.03 and $48.00, last $39.08. 9 sale and 1 purchase filings by 10 insiders, marked at their filing dates. Bindley Capital Partners I, LLC, 10% owner: sold $106.0M across 1 filing, first filed Mar 24, 2026, last Mar 24, 2026. Thomas J. Salentine Jr., Director: sold $106.0M across 1 filing, first filed Mar 24, 2026, last Mar 24, 2026. William E. Bindley, Director: sold $106.0M across 1 filing, first filed Mar 24, 2026, last Mar 24, 2026. John Ackerman, Director: sold $32.8M across 1 filing, first filed Mar 24, 2026, last Mar 24, 2026. Pharmacy Investors, LLC, Other: sold $24.6M across 1 filing, first filed Mar 24, 2026, last Mar 24, 2026. Fred Burke, Officer (see filing): sold $19.9M across 1 filing, first filed Mar 24, 2026, last Mar 24, 2026. Steven D. Cosler, Director: bought $99.8K across 1 filing, first filed Dec 5, 2025, last Dec 5, 2025. 3 others: sold $24.1M across 3 filings, first filed Mar 24, 2026, last Mar 24, 2026.
Largest mark · tap a row for others
Bindley Capital Partners I, LLC · 10% owner
Sale $105,986,620
3,570,677 shares at $29.68 avg
Filed Mar 24, 2026 · traded Mar 20
Close on filing date $37.57
Bindley Capital Partners I, LLC · 10% owner
10% owner
$106.0M soldThomas J. Salentine Jr. · Director
Director
$106.0M soldWilliam E. Bindley · Director
Director
$106.0M soldJohn Ackerman · Director
Director
$32.8M soldPharmacy Investors, LLC · Other
Other
$24.6M soldFred Burke · Officer (see filing)
Officer (see filing)
$19.9M soldSteven D. Cosler · Director
Director
$99.8K bought3 others
Combined, one mark per week
$24.1M soldOpen-market trades
10 filings in the last 12 months| Insider | Role | Sold | Bought | Filings | Pre-arranged (10b5-1) | Last filed |
|---|---|---|---|---|---|---|
| Bindley Capital Partners I, LLC | 10% owner | $106.0M | — | 1 | — | |
| Thomas J. Salentine Jr. | Director | $106.0M | — | 1 | — | |
| William E. Bindley | Director | $106.0M | — | 1 | — | |
| John Ackerman | Director | $32.8M | — | 1 | — | |
| Pharmacy Investors, LLC | Other | $24.6M | — | 1 | — | |
| Fred Burke | Officer (see filing) | $19.9M | — | 1 | — | |
| Kendall Forbes | Officer (see filing) | $10.3M | — | 1 | — | |
| Cardinal Equity Fund, L.P. | Other | $8.2M | — | 1 | — | |
| David K. Morris | Officer (see filing) | $5.6M | — | 1 | — | |
| Steven D. Cosler | Director | — | $99.8K | 1 | — |
| Filed | Insider | Type | Shares | Avg price | Value | Held after | Source |
|---|---|---|---|---|---|---|---|
traded | Cardinal Equity Fund, L.P. Other | Sale | 275,728 | $29.68 | $8.2M | 345,123 | |
traded | Kendall Forbes Officer (see filing) | Sale | 346,672 | $29.68 | $10.3M | 453,256 | |
traded | William E. Bindley Director | Sale | 3,570,677 | $29.68 | $106.0M | 4,469,316 | |
traded | John Ackerman Director | Sale | 1,103,364 | $29.68 | $32.8M | Multiple accounts | |
traded | Bindley Capital Partners I, LLC 10% owner | Sale | 3,570,677 | $29.68 | $106.0M | 4,469,316 | |
traded | Thomas J. Salentine Jr. Director | Sale | 3,570,677 | $29.68 | $106.0M | 4,469,316 | |
traded | Fred Burke Officer (see filing) | Sale | 671,432 | $29.68 | $19.9M | 840,413 | |
traded | Pharmacy Investors, LLC Other | Sale | 827,636 | $29.68 | $24.6M | 1,035,928 | |
traded | David K. Morris Officer (see filing) | Sale | 187,855 | $29.68 | $5.6M | 254,472 | |
traded | Steven D. Cosler Director | Purchase | 3,370 | $29.61 | $99.8K | 24,984 |
GET /stocks/filings/vX/form-4?tickers=GRDN&filing_date.gte=2025-10-26&sort=filing_date.desc&limit=500{
"status": "OK",
"results": [
{
"tickers": [
"GRDN"
],
"issuer_cik": "0001802255",
"owner_cik": "0002038507",
"accession_number": "0001193125-26-121836",
"form_type": "4",
"filing_date": "2026-03-24",
"period_of_report": "2026-03-20",
"issuer_name": "Guardian Pharmacy Services, Inc.",
"issuer_trading_symbol": "GRDN",
"owner_name": "Forbes Kendall",
"is_director": false,
"is_officer": true,
"is_ten_percent_owner": false,
"is_other": false,
"officer_title": "See Remarks",
"security_type": "non_derivative",
"record_type": "transaction",
"security_title": "Class A Common Stock",
"transaction_timeliness": "O",
"aff_10b5_one": false,
"transaction_date": "2026-03-20",
"transaction_code": "S",
"equity_swap_involved": false,
"transaction_shares": 346672,
"transaction_price_per_share": 29.6825,
"transaction_acquired_disposed": "D",
"shares_owned_following_transaction": 453256,
"transaction_value": 10290091.64,
"direct_or_indirect": "D",
"footnotes": [
{
"id": "F1",
"description": "Represents shares of Class A common stock, par value $0.001 per share, of Guardian Pharmacy Services, Inc. (the \"Issuer\"), sold pursuant to the Underwriting Agreement, dated March 18, 2026, by and among the Issuer, the selling stockholders party thereto, and BofA Securities, Inc. and Jefferies LLC, as representatives of the several underwriters named therein."
}
],
"remarks": "Executive Vice President, Sales & Operations"
},
{
"tickers": [
"GRDN"
],
"issuer_cik": "0001802255",
"owner_cik": "0002037898",
"accession_number": "0001193125-26-121839",
"form_type": "4",
"filing_date": "2026-03-24",
"period_of_report": "2026-03-20",
"issuer_name": "Guardian Pharmacy Services, Inc.",
"issuer_trading_symbol": "GRDN",
"owner_name": "Ackerman John",
"is_director": true,
"is_officer": false,
"is_ten_percent_owner": false,
"is_other": false,
"security_type": "non_derivative",
"record_type": "transaction",
"security_title": "Class A Common Stock",
"transaction_timeliness": "O",
"aff_10b5_one": false,
"transaction_date": "2026-03-20",
"transaction_code": "S",
"equity_swap_involved": false,
"transaction_shares": 827636,
"transaction_price_per_share": 29.6825,
"transaction_acquired_disposed": "D",
"shares_owned_following_transaction": 1035928,
"transaction_value": 24566305.57,
"direct_or_indirect": "I",
"nature_of_ownership": "By Pharmacy Investors, LLC",
"footnotes": [
{
"id": "F1",
"description": "Represents shares of Class A common stock, par value $0.001 per share, of Guardian Pharmacy Services, Inc. (the \"Issuer\"), sold pursuant to the Underwriting Agreement, dated March 18, 2026, by and among the Issuer, the selling stockholders party thereto and BofA Securities, Inc. and Jefferies LLC, as representatives of the several underwriters named therein."
}
]
}
]
}
// trimmed to 2 resultsThe response includes every Form 4 record; this page keeps open-market purchases and sales on common stock and removes duplicate joint-filer rows.
Other insider activity (not market trades) · 34 records
- Option exercises27 records
- Grants and awards5 records
- Gifts2 records
Reported on Form 4 but not purchases or sales in the market, so not counted in the totals above.
How to read this page
- Open-market purchase or sale
- A buy or sell of the company's stock at market price. Grants, option exercises, shares withheld for tax, gifts and employee stock plan purchases are listed separately and not counted.
- Filing date
- Insiders have two business days to report a trade. Totals and the chart use the filing date, when the trade became public.
Frequently asked questions
How current is GRDN’s insider data?
These are GRDN Form 4 filings from the last year, refreshed daily. The Massive Form 4 API has the full, continuously updated record.
What counts as an open-market buy or sell?
Only purchases and sales at the market price. Option exercises, grants, gifts, and shares withheld for taxes are reported on Form 4 but are left out of the buy and sell totals.
Build with AI
Track GRDN insider trades with your agent
This page joins two Massive endpoints: Form 4 filings and daily prices. Ask an agent to watch for new filings:
Using the Massive API (massive.com/docs/llms.txt), check Form 4 filings for GRDN every day with transaction_code=P and tell me when an insider files an open-market purchase, with their role, shares, price and the filing link.
Nothing on this page is investment advice. All data and content is provided for informational purposes under our Terms of Service.